Content about Pharmacology

February 7, 2014

Several retail pharmacy chains and associations are pledging their support of the Blue Button Initiative — a public-private partnership between the healthcare industry and the federal government that aims to empower all Americans with access to their own electronic health information, the Office of the National Coordinator for Health IT and the White House Office of Science and Technology Policy have announced.

WASHINGTON — Several retail pharmacy chains and associations are pledging their support of the Blue Button Initiative — a public-private partnership between the healthcare industry and the federal government that aims to empower all Americans with access to their own electronic health information, the Office of the National Coordinator for Health IT and the White House Office of Science and Technology Policy have

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

Dr. Anita Goel, M.D., Ph.D.

February 7, 2014

In light of the evolving healthcare landscape, USA Today published an article on Friday about how pharmacists are increasingly working with doctors to assess patients, identify drug interactions and medication errors and, in some cases, even write a prescription.

The nation’s pharmacies are no longer just for prescription medications and states are proving to be the enablers to a broader the scope of practice.

In light of the evolving healthcare landscape, USA Today published an article on Friday about how pharmacists are increasingly working with doctors to assess patients, identify drug interactions and medication errors and, in some cases, even write a prescription.

February 7, 2014

The January/February 2014 Vitamins and Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Vitamints Immune, Centrum Specialist Immune Support, Alive! Children's Multi-Vitamin Gummy, Natrol's Melatonin, VitaMelts Multi, TruBiotics, Align and Culturelle Digestive Health Capsules.

The January/February 2014 Vitamins and Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Vitamints Immune, Centrum Specialist Immune Support, Alive! Children's Multi-Vitamin Gummy, Natrol's Melatonin, VitaMelts Multi, TruBiotics, Align and Culturelle Digestive Health Capsules.

February 6, 2014

The National Association of Boards of Pharmacy, along with a coalition of healthcare industry stakeholders, on Wednesday issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances.

MOUNT PROSPECT, Ill. — The National Association of Boards of Pharmacy, along with a coalition of healthcare industry stakeholders, on Wednesday issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances. 

February 6, 2014

The Food and Drug Administration’s proposed rule on prescription drug labeling would add $4 billion annually to the nation’s healthcare costs, undercutting the cost savings that generic medicines have brought to America’s patients and healthcare system, according to an analysis released Wednesday by economic consulting firm Matrix Global Advisors.

WASHINGTON — The Food and Drug Administration’s proposed rule on prescription drug labeling would add $4 billion annually to the nation’s healthcare costs, undercutting the cost savings that generic medicines have brought to America’s patients and healthcare system, according to an analysis released Wednesday by economic consulting firm Matrix Global Advisors.

February 6, 2014

The Associated Press on Tuesday reported that New York's online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah.

ALBANY, N.Y. — The Associated Press on Tuesday reported that New York's online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah. 

The Internet System for Tracking Over-Prescribing, called I-STOP, began operating in August, AP reported. 

February 6, 2014

In response to CVS Caremark's announcement to pull tobacco products out of its stores, Walgreens stated that the category has been under review at its stores, too.

DEERFIELD, Ill. — In response to CVS Caremark's announcement to pull tobacco products out of its stores, Walgreens stated that the category has been under review at its stores, too.

Walgreens has been evaluating its tobacco line for “some time,” and said it “will continue to evaluate the choice of products our customers want, while also helping to educate them and providing smoking cessation products and alternatives that help reduce the demand for tobacco products,” noted Michael Polzin, Walgreens spokesperson.

February 6, 2014

West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report.

CHARLESTON, W.Va. — West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report

According to the report, the bill would allow an exception for certain over-the-counter drugs that are deemed "tamper resistant" by the Board of Pharmacy.

February 5, 2014

GlaxoSmithKline Consumer Healthcare and Walgreens on Wednesday teamed up to launch Sponsorship to Quit, a free online quit-smoking program that smokers can personalize with customized tools and tips during their journey to quit.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare and Walgreens on Wednesday teamed up to launch Sponsorship to Quit, a free online quit-smoking program that smokers can personalize with customized tools and tips during their journey to quit. 

February 5, 2014

Inergetics on Tuesday announced it has entered into a strategic partnership with Terra Tech Corp, a fast-growing urban agricultural company, to jointly develop a line of natural cannibidiol-based nutritional supplements.

NEWARK, N.J. — Inergetics on Tuesday announced it has entered into a strategic partnership with Terra Tech Corp, a fast-growing urban agricultural company, to jointly develop a line of natural cannibidiol-based nutritional supplements.

The strategic partnership will combine Inergetics' expertise in successfully developing and marketing innovative nutritional supplements that help consumers lead better and healthier lives with Terra Tech's agricultural expertise and established distribution network of dispensaries in medical cannabis markets.

February 4, 2014

The Food and Drug Administration on Tuesday unveiled its first youth tobacco prevention program, “The Real Cost,” which will target at-risk youth ages 12 to 17 who are open to smoking or already experimenting with cigarettes.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday unveiled its first youth tobacco prevention program, “The Real Cost,” which will target at-risk youth ages 12 to 17 years who are open to smoking or already experimenting with cigarettes. About 10 million youth in the United States currently fall into this category.

The campaign launches nationally Feb. 11. 

February 4, 2014

Reps. Bill Johnson, R-Ohio, and Bruce Braley, D-Iowa, last week introduced bipartisan legislation — the Preventing Abuse of Cough Medicine Treatment Act — that would help combat the abuse of dextromethorphan by placing an age restriction on its purchase.

WASHINGTON — Reps. Bill Johnson, R-Ohio, and Bruce Braley, D-Iowa, last week introduced bipartisan legislation — the Preventing Abuse of Cough Medicine Treatment Act — that would help combat the abuse of dextromethorphan by placing an age restriction on its purchase. 

February 4, 2014

Sanofi and its U.S. consumer healthcare division Chattem on Tuesday announced that Nasacort Allergy 24HR Nasal Spray is now available over the counter in the United States to relieve seasonal and year-round nasal allergy symptoms, including nasal congestion, in adults and children 2 years of age and older.

BRIDGEWATER, N.J. — Sanofi and its U.S. consumer healthcare division Chattem on Tuesday announced that Nasacort Allergy 24HR Nasal Spray is now available over the counter in the United States to relieve seasonal and year-round nasal allergy symptoms, including nasal congestion, in adults and children 2 years of age and older.  

February 4, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday announced a partnership with the National Institutes of Health that will help spur drug development, the association stated.

WASHINGTON — The Pharmaceutical Research and Manufacturers of America on Tuesday announced a partnership with the National Institutes of Health that will help spur drug development, the association stated. 

The Accelerating Medicines Partnership — an initiative of NIH, several non-profit disease foundations, 10 biopharmaceutical companies and PhRMA — aims to transform the current model for developing new diagnostics and treatments by joining forces to identify and validate promising biological targets of disease. 

February 3, 2014

The Food and Drug Administration is investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products, the agency announced Friday.

SILVER SPRING, Md. — The Food and Drug Administration is investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products, the agency announced Friday. 

February 3, 2014

The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization.

WASHINGTON — The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization. 

February 3, 2014

Mylan on Monday announced that its subsidiary has launched the world's first trastuzumab biosimilar in India, which will be marketed by Mylan as Hertraz.

MUMBAI and PITTSBURGH — Mylan on Monday announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India. The product — which will be marketed by Mylan as Hertraz — is used for the treatment of HER2-positive metastatic breast cancer. Hertraz is a biosimilar to Roche's Herceptin and is available in two strengths:  440mg and 150mg.

February 3, 2014

HIT policy needs to focus on specific goals for improving patient medication adherence in order to realize the goals of improving patient health and achieving cost savings in the U.S. healthcare system.

WASHINGTON — HIT policy needs to focus on specific goals for improving patient medication adherence in order to realize the goals of improving patient health and achieving cost savings in the U.S. healthcare system, according to an expert panel convened today by the Network for Excellence in Health Innovation and Prescriptions for a Healthy America.

In particular, the panel said the two highest priorities for HIT should be providing electronic access to accurate mediation lists and complete drug formulary information for prescribing physicians.

February 3, 2014

Script Relief launched a new and improved HelpRx website that, according to the company, aims to provide a user-friendly experience and additional resources to people searching for prescription drug discounts, as well as information about medications.

NEW YORK — Script Relief launched a new and improved HelpRx website that aims to provide a user-friendly experience and additional resources to people searching for prescription drug discounts, as well as information about medications.

Consumers can use the Rx Search tool on the website to find prescription drug coupouns, which can be printed or sent to a user's email address or mobile phone. The coupons can be presented at more than 50,000 pharmacies across the nation, which savings reaching up to 75% off the prescription's retail price, the company said.

January 31, 2014

Actavis on Friday announced a realignment of its global strategic business structure to maximize the company's newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis' position for continued long-term growth.

DUBLIN — Actavis on Friday announced a realignment of its global strategic business structure to maximize the company's newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis' position for continued long-term growth. 

January 31, 2014

Following the announcement that Rep. Henry Waxman, D-Calif., intended to retire, the Generic Pharmaceutical Association bid adieu to a legislator who had a tremendous positive impact on the generic industry.

WASHINGTON — Following the announcement that Rep. Henry Waxman, D-Calif., intended to retire, the Generic Pharmaceutical Association on Thursday bid adieu to a legislator who had a tremendous positive impact on the generic industry. 

January 31, 2014

The Biotechnology Industry Organization and the Indiana Health Industry Forum commended the Indiana Senate for passing legislation designed to create a pathway for the substitution of interchangeable biologic medicines.

WASHINGTON — The Biotechnology Industry Organization and the Indiana Health Industry Forum on Thursday commended the Indiana Senate for passing legislation designed to create a pathway for the substitution of interchangeable biologic medicines.

The policies outlined in the identical SB 262 align with BIO’s principles on biologic substitution, therefore BIO and IHIF support passage of this bill as it moves along for consideration by the Indiana House of Representatives.

January 31, 2014

Mylan announced that its India-based subsidiary, Mylan Pharmaceuticals Private Limited, has been named Gilead Sciences' branded medicines business partner for India.

PITTSBURGH and MUMBAI, India — Mylan announced that its India-based subsidiary, Mylan Pharmaceuticals Private Limited, has been named Gilead Sciences' branded medicines business partner for India.

Under this exclusive agreement, Mylan will market and distribute in India the following drugs from Gilead:

January 31, 2014

Valeant Pharmaceuticals International announced that it received approval from the Food and Drug Administration for Retin-A Micro (tretinoin) gel microsphere 0.08%.

LAVAL, Quebec — Valeant Pharmaceuticals International, a specialty pharmaceutical company, on Friday announced that it received approval from the Food and Drug Administration for Retin-A Micro (tretinoin) gel microsphere 0.08%, which is used for the topical treatment of acne vulgaris.